ReviewAdvanced materials (Deerfield Beach, Fla.)2026
Immunoengineering External Field Responsive Biomaterials for Tissue Repair and Regeneration.
Review in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Tissue defect repair is a dynamic process involving inflammation regulation, angiogenesis, organized extracellular matrix assembly, and immune microenvironment homeostasis. Its success critically depends on repair strategies with precise spatiotemporal control. External field-responsive biomaterials (EFRBs), which respond to optical, magnetic, electrical, ultrasonic, and thermal stimuli, have become a research focus in regenerative medicine due to their on-demand activation, unique (bio)physicochemical properties, and ability to modulate immune-related pathways. This review first outlines the dynamic biological requirements of tissue repair, including the immune microenvironment's role, and the core advantages of EFRBs. It then details the structural features and external field response mechanisms of various EFRBs-such as nanoparticles, scaffolds, hydrogels, and microneedles-and their regulatory effects on immune-related repair processes. Finally, it systematically summarizes recent advances in immunoengineering EFRBs for enhancing tissue repair and regeneration. This review thus aims to provide valuable insights for optimizing EFRB-based therapies and to inspire further breakthroughs in this evolving field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.